2023-11-13T09:31:36-06:00 2022-12-31 882730877 CHERRY BEKAERT ADVISORY LLC 6116 EXECUTIVE BLVD STE 600 ROCKVILLE MD 20852 990 2022-01-01 311671642 ASSOCIATION FOR MOLECULAR PATHOLOGY INC ASSO 3016847987 6120 EXECUTIVE BLVD SUITE 700 ROCKVILLE MD 20852 MARY STEELE WILLIAMS EXECUTIVE DIRECTOR 3016847987 2023-11-09 1 MARY STEELE WILLIAMS 999009999 0 RAYMOND BARBAGALLO P00173692 3015899000 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z MARY STEELE WILLIAMS 6120 EXECUTIVE BLVD SUITE 700 ROCKVILLE MD 20852 14403929 0 X WWW.AMP.ORG X 1999 MD THE ASSOCIATION FOR MOLECULAR PATHOLOGY IS A NOT-FOR-PROFIT SCIENTIFIC SOCIETY THAT ADVANCES THE CLINICAL PRACTICE, SCIENCE, AND EXCELLENCE OF MOLECULAR AND GENOMIC LABORATORY MEDICINE THROUGH EDUCATION, INNOVATION, AND ADVOCACY TO ENABLE HIGHEST QUALITY HEALTH CARE. 17 17 22 361 83100 0 2102840 2271272 1976652 4379508 197981 2247225 0 0 4277473 8898005 7500 56863 0 0 2561792 2663705 0 0 0 2030852 3067485 4600144 5788053 -322671 3109952 16438926 14807371 3763479 2524028 12675447 12283343 X ADVANCES THE CLINICAL PRACTICE, SCIENCE, AND EXCELLENCE OF MOLECULAR AND GENOMIC LABORATORY MEDICINE THROUGH EDUCATION, INNOVATION, AND ADVOCACY TO ENABLE HIGHEST QUALITY HEALTH CARE. 0 0 2387639 56863 3796084 EDUCATION - SEE SCHEDULE O FOR COMPLETE DESCRIPTION 202822 454854 COMMUNICATION & OUTREACH: MEMBERSHIP SERVICES - WEBSITE, NEWSLETTERS, ETC.PROMOTE GENERAL EFFECTIVENESS AND PROVIDE A FORUM FOR DISCUSSION AND A MEANS OF EXCHANGING INFORMATION. 549756 45470 INNOVATION & IMPROVED PATIENT CARE - SEE SCHEDULE O FOR COMPLETE DESCRIPTIONTHE JOURNAL OF MOLECULAR DIAGNOSTICSTHIS IS THE OFFICIAL JOURNAL OF AMP. MONTHLY PUBLICATION BEGAN IN JANUARY 2020. THESE ISSUES HAVE ORIGINAL, HIGH-QUALITY MANUSCRIPTS ON SCIENTIFIC ADVANCES IN THE TRANSLATION AND VALIDATION OF MOLECULAR DISCOVERIES IN MEDICINE INTO THE CLINICAL DIAGNOSTIC SETTING, AND THE DESCRIPTION AND APPLICATION OF TECHNOLOGICAL ADVANCES IN THE FIELD OF MOLECULAR DIAGNOSTIC MEDICINE.EVERY PUBLISHED MANUSCRIPT IS SCIENTIFICALLY PEER REVIEWED.JMD IS JOINTLY OWNED WITH THE AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY (ASIP) 94-6079945. STARTING IN 2011, ELSEVIER BEGAN PUBLISHING JMD. 930744 0 ADVOCACYTHE AMP ADVOCACY PROGRAM ENDEAVORS TO INFORM AND INFLUENCE PUBLIC POLICY AFFECTING MOLECULAR PATHOLOGY. AMP REPRESENTS ITS MEMBERSHIP TO THE FEDERAL AGENCIES AND MEMBERS OF CONGRESS REGARDING PROFESSIONAL AND REIMBURSEMENT ISSUES - REACHING OUT TO FELLOW PROFESSIONAL ASSOCIATIONS, INDUSTRY AND OTHER ASSOCIATION PARTNERS TO ACCOMPLISH COMMON GOALS. 930744 0 4070961 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 37 0 1 22 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 17 17 0 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X ASSOCIATION FOR MOLECULAR PATHOLOGY INC 3016847987 6120 EXECUTIVE BLVD SUITE 700 ROCKVILLE MD 20852 DANIEL E SABATH MD PHD PRESIDENT 2.00 X X 0 0 0 ANTONIA R SEPULVEDA MD PHD PAST PRESIDENT & NOMINATING COMMITTEE CHAIR 2.00 X X 0 0 0 LAURA J TAFE MD PRESIDENT-ELECT; AWARDS & STRATEGIC OPPORTUNITIES 2.00 X X 0 0 0 ALEXIS B CARTER MD SECRETARY-TREASURER 2.00 X X 0 0 0 SHELBY MELTON MD MEMBERSHIP AFFAIRS COMMITT 2.00 X 0 0 0 ERIC KONNICK MD MS PROFESSIONAL RELATIONS COM 2.00 X 0 0 0 ALANNA CHURCH MD TRAINING & EDUCATION COMM 2.00 X 0 0 0 DONNA M WOLK PHD DABMM INFECTIOUS DISEASES SUBDIV 2.00 X 0 0 0 JANE GIBSON PHD CLNICAL PRACTICE COMMITTEE 2.00 X 0 0 0 AVNI SANTANI BS PHD GENETICS SUBDIVISION CHAIR 2.00 X 0 0 0 JASON D MERKER MD PHD INFORMATICS SUBDIVISION CH 2.00 X 0 0 0 SAMUEL K CAUGHRON MD ECONOMIC AFFAIRS COMMITTEE 2.00 X 0 0 0 NIRALI PATEL MD PROGRAM COMMITTEE CHAIR 2.00 X 0 0 0 PATRICIA TSANG MD PUBLICATION/COMMUNICATION 2.00 X 0 0 0 ERIC DUNCAVAGE MD HEMATOPATHOLOGY SUBDIVISIO 2.00 X 0 0 0 ANNA YEMELYANOVA MD SOLID TUMORS SUBDIVISION C 2.00 X 0 0 0 RAMI MAHFOUZ MD MPH INTERNATIONAL AFFAIRS COMM 2.00 X 0 0 0 MARY STEELE WILLIAMS MNA MT ASCPSM EXECUTIVE DIRECTOR 40.00 X 320553 0 47389 ROBYN TEMPLE-SMOLKIN DIR CLINICAL/SCIENTIFIC AF 40.00 X 137906 0 40192 LAUREN S MENSER DIRECTOR OF STRATEGIC DEVE 40.00 X 170250 0 26916 SARA HAMILTON DIRECTOR OF MEETINGS & EXH 40.00 X 137179 0 22951 ERIKO CLEMENTS DIRECTOR OF EDUCATION PROGRAMS 40.00 X 122820 0 35133 SARAH A THIBAULT-SENNETT DIRECTOR OF PUBLIC POLICY AND ADVOCACY 40.00 X 137652 0 21836 1026360 0 194417 6 0 1 0 AVENTURA CATERING 100 NORTH THIRD STREET PHOENIX AZ 85004 FOOD & BEVERAGE 353061 PROJECTION PRESENTATION TECHNOLOGY PO BOX 890472 CHARLOTTE NC 282890472 AUDIO/VISUAL SERVICES 288065 INNOVATION POLICY SOLUTIONS LLC 1012 14TH STREET NW SUITE 500 WASHINGTON DC 20005 GOVERNMENT RELATIONS 193056 PHOENIX CONVENTION CENTER 100 THIRD STREET PHOENIX AZ 85004 CONVENTION CENTER RENTAL 152345 CAVAROCCHI RUSCIO DENNIS ASSOC LLC 600 MARYLAND AVE SW SUITE 220 EA WASHINGTON DC 20024 GOVERNMENT RELATIONS 108913 5 2271272 2271272 EDUCATION 541900 3879184 3796084 83100 MEMBERSHIP DUES 541900 391354 391354 MAILING LIST RENTALS 541900 63500 63500 JMD CME PROGRAM 541900 45470 45470 4379508 202434 202434 7550715 5505924 2044791 2044791 2044791 8898005 4296408 83100 2247225 X 56863 56863 367943 367943 1790841 1606027 184814 169948 133402 36546 186453 143997 42456 148520 96166 52354 8761 7850 911 62765 62765 49815 49815 705033 587907 117126 28112 25050 3062 295776 157883 137893 44250 44250 266755 266755 1244811 1139191 105620 159333 159333 13812 1181 12631 GRANT EXPENSES 112344 112344 CORPORATE PARTNERSHIPS 72818 72818 GRASSROOTS COMMUNICATIO 3100 3100 5788053 4070961 1717092 0 2854943 2091386 192630 146597 185966 213909 895866 492467 534139 403399 11026631 10502337 1625052 1430178 19565 19565 16438926 14807371 238612 212330 1605887 599397 1918980 1712301 3763479 2524028 X 12226815 12283343 448632 0 12675447 12283343 16438926 14807371 3109952 -3505552 3496 0 X 0 0 0 X 993430 1061239 925395 2102840 2271272 7354176 4822508 5012002 2827834 1946652 4296408 18905404 5815938 6073241 3753229 4049492 6567680 26259580 0 0 0 26259580 170020 221538 184051 197981 202434 976024 170020 221538 184051 197981 202434 976024 30000 83100 113100 5985958 6294779 3937280 4277473 6853214 27348704 0.96020 0.96230 0.03570 0.03650 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3995 84983 88978 5649261 5738239 436912 109228 0 0 427665 368573 369656 436912 1602806 2404209 76869 14852 47303 88978 228002 106916 92143 92414 109228 400701 601052 3000 3434 4196 3995 14625 895866 492467 403399 403399 LEASE LIABILTY 1712301 1712301 1 AWARD FOR EXCELLENCE 1 7500 TECHNOLOGIST POSTER 18 9750 TECHNOLOGIST TRAVEL 21 29688 PART I, LINE 2: ASSOCIATION FOR MOLECULAR PATHOLOGY HAS AN AWARDS COMMITTEE WHICH CHOOSES AWARD RECIPIENTS AND MONITORS THE USE OF THOSE AWARDS. THE COMMITTEE ACCEPTS NOMINATIONS FROM THE MEMBERSHIP AND COMPILES SUGGESTIONS FROM THE COMMITTEE AS WELL. THE AWARD FOR EXCELLENCE RECIPIENTS ARE SELECTED TWO YEARS PRIOR TO THE AWARD BEING PRESENTED AT THE AMP ANNUAL MEETING & EXPO. THE RECIPIENT OF THE AWARD PRESENTS A SPECIAL LECTURE AT THE MEETING. X 1 1 X X X X 0 0 0 0 0 0 0 0 0 MARY STEELE WILLIAMS MNA MT ASCPSM EXECUTIVE DIRECTOR 320553 0 0 0 0 0 28050 0 19339 0 367942 0 0 0 LAUREN S MENSER DIRECTOR OF STRATEGIC DEVE 170250 0 0 0 0 0 15383 0 11533 0 197166 0 0 0 ROBYN TEMPLE-SMOLKIN DIR CLINICAL/SCIENTIFIC AF 137906 0 0 0 0 0 13960 0 26232 0 178098 0 0 0 SARA HAMILTON DIRECTOR OF MEETINGS & EXH 137179 0 0 0 0 0 13000 0 9951 0 160130 0 0 0 SARAH A THIBAULT-SENNETT DIRECTOR OF PUBLIC POLICY AND ADVOCA 137652 0 0 0 0 0 12002 0 9834 0 159488 0 0 0 ERIKO CLEMENTS DIRECTOR OF EDUCATION PROGRAMS 122820 0 0 0 0 0 12875 0 22258 0 157953 0 0 0 PART I, LINE 1A PER THE EMPLOYMENT CONTRACT, THE EXECUTIVE DIRECTOR HAS USE OF A DISCRETIONARY EXPENSE ACCOUNT, UP TO $10,000 PER YEAR, FOR OFFICE AND UPGRADED BUSINESSS TRAVEL EXPENSES, PROFESSIONAL DEVELOPMENT AND INDIVIDUAL LONG TERM CARE INSURANCE. THE FUNDS ARE NOT TAXABLE TO THE EXECUTIVE DIRECTOR. FORM 990, PART III, LINE 4A SCIENTIFIC SYMPOSIA AND MEETINGS: THE ORGANIZATION BRINGS TOGETHER SCIENTISTS FOR THE PROMOTION OF CLINICAL PRACTICE, BASIC RESEARCH, AND EDUCATION IN MOLECULAR PATHOLOGY. IN 2022, AMP'S ANNUAL MEETING & EXPO WAS HELD IN PHOENIX, ARIZONA. THIS THREE-DAY EVENT FEATURED MORE THAN 25 HOURS OF CUTTING-EDGE SESSIONS, A KEYNOTE PRESENTATION BY THE AMP 2022 AWARD FOR EXCELLENCE RECIPIENT, MORE THAN 434 POSTERS, 195 EXHIBITORS, AND COUNTLESS OPPORTUNITIES TO INTERACT DIRECTLY WITH COLLEAGUES. THERE WERE 1,855 REGISTRANTS AND 98 SPEAKERS. AMP HOLDS AN INTERACTIVE COURSE DESIGNED TO BRING ATTENDEES UP TO SPEED IN MOLECULAR PATHOLOGY CALLED GET AMPED! UPDATES AND CASE STUDIES IN MOLECULAR PATHOLOGY. IN 2022, THE EVENT WAS OFFERED AS AN INTERACTIVE-ONLINE LEARNING EXPERIENCE IN JANUARY AND A LIVE EDUCATIONAL EVENT IN NOVEMBER. THE TOPICS INCLUDED CURRENT MOLECULAR HOT TOPICS, PREANALYTICAL VARIABLES AND WORKFLOW CONSIDERATIONS THAT IMPACT MOLECULAR TESTING, AND AN OVERVIEW OF CURRENT MOLECULAR TECHNOLOGY INCLUDING THE APPLICATION OF MODERN TECHNOLOGIES SUCH AS NEXT GENERATION SEQUENCING AND INFORMATICS. FACULTY MEMBERS PRESENT AN IMMERSIVE WORKSHOP OF CASE STUDIES WHERE PARTICIPANTS BREAKOUT INTO SMALL GROUPS TO WORK THROUGH CLINICAL MOLECULAR CASES. MOLECULAR GENETIC PATHOLOGY REVIEW COURSE AMP HAD ITS FIRST MGP REVIEW COURSE IN 2007. IT THEN HAD A LIVE EVENT IN THE ODD YEARS FROM 2009 THROUGH 2021. THE 2021 COURSE WAS PROVIDED AS A LIVE VIRTUAL COURSE. THE LIVE EVENT WAS RECORDED STARTING IN 2017 AND OFFERED AS AN ONLINE COURSE UNTIL THE NEXT LIVE COURSE WAS OFFERED. THE REVENUE FROM RECORDED SESSIONS IS ACCOUNTED FOR IN ONLINE EDUCATION. THE COURSE FEATURES MULTI-DAY INTENSE INSTRUCTION ON UPDATES IN THE FIELD AND REVIEW OF MOLECULAR PATHOLOGY CORE CONCEPTS THAT IS PRIMARILY FOCUSED ON PREPARATION FOR THE MOLECULAR GENETIC PATHOLOGY (MGP) SUBSPECIALTY CERTIFICATION EXAM, AS WELL AS OTHER CERTIFICATION EXAMS. IN 2022, ONLY THE ONLINE RECORDED COURSE WAS AVAILABLE FOR PURCHASE. AMP DID NOT HOLD AN INTERNATIONAL MEETING IN 2022 DUE TO RESTRICTIONS RELATED TO THE COVID-19 GLOBAL PANDEMIC. FORM 990, PART VI, SECTION A, LINE 6 THE FOLLOWING ARE AMP'S MEMBERSHIP CATEGORIES: SEE WWW.AMP.ORG/MEMBERSHIP/JOIN-RENEW/ FOR ADDITIONAL DESCRIPTIONS. 1) REGULAR MEMBERS 2) TECHNOLOGIST MEMBERS 3) EARLY CAREER MEMBERS 4) ASSOCIATE MEMBERS (STUDENTS, FELLOWS, RESIDENTS) 5) EMERITUS MEMBERS (RETIRED REGULAR MEMBERS) 1) REGULAR MEMBERS ARE INDIVIDUALS INVOLVED IN THE EDUCATIONAL, MEDICAL, SCIENTIFIC, ECONOMIC, AND/OR REGULATORY ASPECTS OF MOLECULAR DIAGNOSTICS, INCLUDING BUT NOT LIMITED TO PATHOLOGISTS, CLINICAL LABORATORY SCIENTISTS, TECHNOLOGISTS, CLINICIANS AND OTHER HEALTH CARE PERSONNEL, GOVERNMENT EMPLOYEES, ESPECIALLY THOSE INVOLVED IN REGULATION OF THE FIELD, AND PROFESSIONALS IN THE IN VITRO DIAGNOSTICS INDUSTRY. REGULAR MEMBERS ARE ELIGIBLE TO VOTE, TO HOLD ELECTED OFFICE, AND TO SERVE ON AMP COMMITTEES. DUES RATES FOR REGULAR MEMBERS VARY DEPENDING ON THE INDIVIDUAL'S COUNTRY OF RESIDENCE AND PLACE OF EMPLOYMENT. VISIT THE MEMBERSHIP DUES RATES PAGE FOR DETAILS. 2) TECHNOLOGIST MEMBERS ARE INDIVIDUALS INVOLVED IN THE CLINICAL PRACTICE AND/OR RESEARCH ASPECTS OF MOLECULAR DIAGNOSTICS WHOSE PRIMARY DUTIES INVOLVE BENCH WORK, DEVELOPING AND/OR PERFORMING TESTS. TECHNOLOGIST MEMBERS ARE ELIGIBLE TO VOTE, TO HOLD ELECTED OFFICE, AND TO SERVE ON AMP COMMITTEES. DUES RATES FOR TECHNOLOGIST MEMBERS VARY DEPENDING ON THE INDIVIDUAL'S COUNTRY OF RESIDENCE AND PLACE OF EMPLOYMENT. VISIT THE MEMBERSHIP DUES RATES PAGE FOR DETAILS. 3) EARLY CAREER MEMBERS ARE INDIVIDUALS WHO WERE ASSOCIATE MEMBERS LAST YEAR AND ARE TRANSITIONING TO REGULAR MEMBER STATUS. DUES RATES FOR EARLY CAREER MEMEBERS VARY DEPENDING ON THE INDIVIDUAL'S COUNTRY OF RESIDENCE AND PLACE OF EMPLOYMENT. VISIT THE MEMBERSHIP DUES RATES PAGE FOR DETAILS. 4) ASSOCIATE MEMBERSHIP IS OPEN TO STUDENTS, POSTDOCTORAL FELLOWS, AND RESIDENTS AT A REDUCED RATE. ASSOCIATE MEMBERSHIP CARRIES ALL THE BENEFITS OF FULL MEMBERSHIP EXCEPT HOLDING ELECTED OFFICE AND VOTING RIGHTS IN AMP ELECTIONS. ASSOCIATE MEMBERS ARE ELIGIBLE TO BE CONSIDERED FOR A JUNIOR MEMBER POSITION ON THE COMMITTEES. CANDIDATES FOR ASSOCIATE MEMBERSHIP MUST INCLUDE COMMUNICATION FROM THEIR PROGRAM DIRECTOR CERTIFYING THE APPLICANT'S TRAINEE STATUS. ASSOCIATE MEMBERS HAVE THE OPTION TO PURCHASE A PRINT SUBSCRIPTION TO THE JOURNAL OF MOLECULAR DIAGNOSTICS TO SUPPLEMENT THE COMPLIMENTARY ONLINE SUBSCRIPTION. VISIT THE MEMBERSHIP DUES RATES PAGE FOR DETAILS. 5) EMERITUS MEMBERSHIP IS OPEN TO REGULAR MEMBERS WHO ARE RETIRED AND ARE NO LONGER RECEIVING EITHER FULL OR PART-TIME SALARY FROM AN INSTITUTION, COMPANY OR ORGANIZATION. CANDIDATES FOR THIS CATEGORY MUST HAVE BEEN A REGULAR AMP MEMBER FOR AT LEAST THE FIVE CONSECUTIVE YEARS IMMEDIATELY PRECEDING APPLICATION FOR EMERITUS STATUS. EMERITUS MEMBERSHIP CARRIES ALL THE BENEFITS OF FULL MEMBERSHIP EXCEPT THE ABILITY TO RUN FOR ELECTED OFFICE OR VOTE IN SOCIETY ELECTIONS. NOTE: AMP RESERVES THE RIGHT TO ACTIVATE OR INACTIVATE MEMBERSHIPS, IN ACCORDANCE WITH AMP BYLAWS AND OPERATING PROCEDURES. FORM 990, PART VI, SECTION A, LINE 7A THE MAJORITY OF THE BOARD OF DIRECTORS IS ELECTED BY AMP'S MEMBERSHIP. ONLY AMP'S REGULAR MEMBERS MAY RUN FOR OFFICE. FORM 990, PART VI, SECTION B, LINE 11B AMP'S FORM 990 IS INITIALLY REVIEWED, IN DRAFT FORM, BY THE EXECUTIVE DIRECTOR. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICTS OF INTEREST DISCLOSURE REPORTS ARE GIVEN TO THE EXECUTIVE DIRECTOR. THE EXECUTIVE DIRECTOR THEN MONITORS THE ISSUES AND ALERTS THE PRESIDENT AND RELEVANT COMMITTEE CHAIR OF ANY APPARENT CONFLICTS. FORM 990, PART VI, SECTION B, LINE 15A THE COMPENSATION OF THE EXECUTIVE DIRECTOR IS APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 AMP'S BYLAWS ARE AVAILABLE ON THE AMP WEBSITE. FORM 990, PART IX, LINE 11G PROFESSIONAL DEVELOPMENT: PROGRAM SERVICE EXPENSES 39,219. MANAGEMENT AND GENERAL EXPENSES 15,151. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 54,370. FASEB: PROGRAM SERVICE EXPENSES 16,198. MANAGEMENT AND GENERAL EXPENSES 69,738. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 85,936. CONTRACTUAL: PROGRAM SERVICE EXPENSES 532,490. MANAGEMENT AND GENERAL EXPENSES 32,237. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 564,727. FORM 990, PART IV, LINE 12A AND PART XIII, LINE 2B THIS RETURN HAS BEEN PREPARED BASED ON PRELIMINARY INFORMATION FROM THE COMPANY'S AUDITED FINANCIAL STATEMENTS. SUCH STATEMENTS AND REPORTS ARE STILL UNDER REVIEW BY THE COMPANY'S INDEPENDENT AUDITOR, AND THUS ARE SUBJECT TO CHANGE. ONCE THE AUDITED FINANCIAL STATEMENTS HAVE BEEN FINALIZED, THIS RETURN WILL BE AMENDED TO REFLECT ANY MATERIAL DIFFERENCES.